Literature DB >> 27155856

Arthroscopic anatomic double-bundle ACL reconstruction using irradiated versus non-irradiated hamstring tendon allograft.

Shaoqi Tian1, Chengzhi Ha2, Bin Wang3, Yuanhe Wang2, Lun Liu2, Qicai Li2, Xu Yang2, Kang Sun4.   

Abstract

PURPOSE: To analyse the clinical outcome of anatomic double-bundle anterior cruciate ligament (ACL) reconstruction with irradiated versus non-irradiated hamstring allograft.
METHODS: One hundred and twelve patients who met the inclusion and exclusion criteria of the study were prospectively randomized consecutively into irradiated hamstring tendon allograft (Ir-Allo) group and non-irradiated allograft (Non-ir-Allo) group. All surgeries were done by the same senior surgeon with double-bundle reconstruction technique. Before surgery and at follow-up points, patients were evaluated by the same observer according to clinical evaluations.
RESULTS: Eighty-three patients (Non-ir-Allo, 44; Ir-Allo, 39) fulfilled complete follow-up and got full clinical evaluations. The mean follow-up period was 5.7 years (ranging from 5.0 to 6.5 years). At the final follow-up, significant differences were found when comparing the results of the two groups according to Lachman test, ADT, pivot shift test and KT-2000 arthrometer testing (P < 0.05). According to KT-2000, 86.4 % of patients in the Non-ir-Auto group and 35.9 % in the Ir-Allo group had a side-to-side difference of <3 mm. According to the overall IKDC, functional, subjective evaluations and activity level testing, no significant differences were found between the two groups. Regarding the arthritic progression, there was significant difference between the two groups (Ir-Allo group: 30.8 %, Non-ir-Allo group: 11.4 %, P < 0.05).
CONCLUSION: A significant increase in anterior and rotational laxity in patients of the Ir-Allo group was found according to evaluations. No significant differences in activity level and functional scores were found between the two groups. We do not advocate the irradiated hamstring tendon allograft for ACL reconstruction. LEVEL OF EVIDENCE: I.

Entities:  

Keywords:  ACL; Anatomic reconstruction; Double-bundle; Hamstring tendon allograft; Irradiation; Prospective randomized study

Mesh:

Year:  2016        PMID: 27155856     DOI: 10.1007/s00167-016-4154-6

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  32 in total

1.  The biomechanical effects of low-dose irradiation on bone-patellar tendon-bone allografts.

Authors:  Andrew R Curran; Douglas J Adams; Julie L Gill; Mark E Steiner; Arnold D Scheller
Journal:  Am J Sports Med       Date:  2004-05-18       Impact factor: 6.202

2.  Relationships between objective assessment of ligament stability and subjective assessment of symptoms and function after anterior cruciate ligament reconstruction.

Authors:  Mininder S Kocher; J Richard Steadman; Karen K Briggs; William I Sterett; Richard J Hawkins
Journal:  Am J Sports Med       Date:  2004 Apr-May       Impact factor: 6.202

Review 3.  Autograft Versus Allograft in Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials and Systematic Review of Overlapping Systematic Reviews.

Authors:  Chao Zeng; Shu-guang Gao; Hui Li; Tuo Yang; Wei Luo; Yu-sheng Li; Guang-hua Lei
Journal:  Arthroscopy       Date:  2015-10-21       Impact factor: 4.772

4.  High-dose gamma irradiation for soft tissue allografts: High margin of safety with biomechanical integrity.

Authors:  Teri A Grieb; Ren-Yo Forng; Simon Bogdansky; Chad Ronholdt; Brent Parks; William N Drohan; Wilson H Burgess; Jack Lin
Journal:  J Orthop Res       Date:  2006-05       Impact factor: 3.494

5.  Arthroscopic anterior cruciate ligament reconstruction with at least 2.5 years' follow-up comparing hamstring tendon autograft and irradiated allograft.

Authors:  Kang Sun; Jihua Zhang; Yan Wang; Changsuo Xia; Cailong Zhang; Tengbo Yu; Shaoqi Tian
Journal:  Arthroscopy       Date:  2011-07-22       Impact factor: 4.772

6.  Allograft versus autograft anterior cruciate ligament reconstruction: 3- to 5-year outcome.

Authors:  C D Harner; E Olson; J J Irrgang; S Silverstein; F H Fu; M Silbey
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

7.  Gamma irradiation: effects on biomechanical properties of human bone-patellar tendon-bone allografts.

Authors:  B M Fideler; C T Vangsness; B Lu; C Orlando; T Moore
Journal:  Am J Sports Med       Date:  1995 Sep-Oct       Impact factor: 6.202

Review 8.  Graft selection in anterior cruciate ligament reconstruction.

Authors:  Robin V West; Christopher D Harner
Journal:  J Am Acad Orthop Surg       Date:  2005 May-Jun       Impact factor: 3.020

9.  Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS).

Authors:  B E Buck; T I Malinin; M D Brown
Journal:  Clin Orthop Relat Res       Date:  1989-03       Impact factor: 4.176

Review 10.  A meta-analysis of stability of autografts compared to allografts after anterior cruciate ligament reconstruction.

Authors:  Chadwick Prodromos; Brian Joyce; Kelvin Shi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-04-17       Impact factor: 4.114

View more
  3 in total

Review 1.  A Systematic Review of Randomized Controlled Trials in Anterior Cruciate Ligament Reconstruction: Standard Techniques Are Comparable (299 Trials With 25,816 Patients).

Authors:  Hosam E Matar; Simon R Platt; Benjamin V Bloch; Peter J James; Hugh U Cameron
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-05-14

2.  Comparison of clinical outcomes of using the nonirradiated and irradiated allograft for anterior cruciate ligament (ACL) reconstruction: A systematic review update and meta-analysis.

Authors:  Yan Liu; Xuegang Liu; Yancai Liu; Shan Yang
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

Review 3.  Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin.

Authors:  C Randall Harrell; Valentin Djonov; Crissy Fellabaum; Vladislav Volarevic
Journal:  Int J Med Sci       Date:  2018-01-18       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.